Amgen Raises 2026 Revenue View to $38.9B-$39.7B
Amgen had previously seen 2026 revenue of $38.2B to $39.4B.
Story updates
09:07:49 PM UTC
SquawkNews
安进第三季度销售额增长8%，主要得益于降胆固醇药和抗癌药的强劲表现 调整后每股收益增长14%，至6.45美元 2026年每股收益预期上调至22.90美元至23.70美元，营收预期为389亿美元至397